Interestingly, this PD-L1 induction following chemotherapies could explain, at least partially, the superiority of chemotherapy/immunotherapy compared to chemotherapy alone even in patients with a PD-L1 score < 1% in tumor [3, 5, 12, 19, 20]. This evidence concerns the gene CD274 and neoplasm.